Beneficial effects of omega-3 fatty acid supplementation in schizophrenia: possible mechanisms
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Beneficial effects of omega-3 fatty acid supplementation in schizophrenia: possible mechanisms
Authors
Keywords
-
Journal
Lipids in Health and Disease
Volume 19, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-07-03
DOI
10.1186/s12944-020-01337-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The gut microbiome from patients with schizophrenia modulates the glutamate-glutamine-GABA cycle and schizophrenia-relevant behaviors in mice
- (2019) Peng Zheng et al. Science Advances
- Cognitive Change in Schizophrenia and Other Psychoses in the Decade Following the First Episode
- (2019) Jolanta Zanelli et al. AMERICAN JOURNAL OF PSYCHIATRY
- Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy people
- (2019) Ayedh Alqarni et al. SCHIZOPHRENIA RESEARCH
- Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial
- (2019) Maximus Berger et al. Frontiers in Psychiatry
- The NEURAPRO biomarker analysis: long-chain omega-3 fatty acids improve 6-month and 12-month outcomes in youth at ultra-high risk for psychosis
- (2019) G Paul Amminger et al. BIOLOGICAL PSYCHIATRY
- Different metabolism of EPA, DPA and DHA in humans: A double-blind cross-over study
- (2019) Xiao-fei Guo et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- Dietary Supplementation with Omega-3 Polyunsaturated Fatty Acids Reduces Opioid-Seeking Behaviors and Alters the Gut Microbiome
- (2019) Joshua K. Hakimian et al. Nutrients
- A potential role for adjunctive omega-3 polyunsaturated fatty acids for depression and anxiety symptoms in recent onset psychosis: Results from a 16 week randomized placebo-controlled trial for participants concurrently treated with risperidone
- (2018) Delbert G. Robinson et al. SCHIZOPHRENIA RESEARCH
- Dietary patterns and physical activity in people with schizophrenia and increased waist circumference
- (2018) Ane Storch Jakobsen et al. SCHIZOPHRENIA RESEARCH
- Metabolic abnormalities and low dietary Omega 3 are associated with symptom severity and worse functioning prior to the onset of psychosis: Findings from the North American Prodrome Longitudinal Studies Consortium
- (2018) Kristin S. Cadenhead et al. SCHIZOPHRENIA RESEARCH
- The Microbiome: A New Target for Research and Treatment of Schizophrenia and its Resistant Presentations? A Systematic Literature Search and Review
- (2018) Alessandro Cuomo et al. Frontiers in Pharmacology
- Fatty acid composition of the postmortem corpus callosum of patients with schizophrenia, bipolar disorder, or major depressive disorder
- (2017) K. Hamazaki et al. EUROPEAN PSYCHIATRY
- A randomised trial of the effect of omega-3 polyunsaturated fatty acid supplements on the human intestinal microbiota
- (2017) Henry Watson et al. GUT
- Impact of Omega-3 Fatty Acids on the Gut Microbiota
- (2017) Lara Costantini et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Oxidative stress reduction related to the efficacy of n-3 polyunsaturated fatty acids in first episode schizophrenia: Secondary outcome analysis of the OFFER randomized trial
- (2017) T. Pawełczyk et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- Identifying neurocognitive markers for outcome prediction of global functioning in individuals with first-episode and ultra-high-risk for psychosis
- (2017) Kingo Sawada et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Effect of ω-3 Polyunsaturated Fatty Acids in Young People at Ultrahigh Risk for Psychotic Disorders
- (2017) Patrick D. McGorry et al. JAMA Psychiatry
- Polyunsaturated fatty acid deficiency during neurodevelopment in mice models the prodromal state of schizophrenia through epigenetic changes in nuclear receptor genes
- (2017) M Maekawa et al. Translational Psychiatry
- Microglial Activity in People at Ultra High Risk of Psychosis and in Schizophrenia: An [11C]PBR28 PET Brain Imaging Study
- (2016) Peter S. Bloomfield et al. AMERICAN JOURNAL OF PSYCHIATRY
- Desaturase and elongase-limiting endogenous long-chain polyunsaturated fatty acid biosynthesis
- (2016) Ji Yao Zhang et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- A randomized controlled study of the efficacy of six-month supplementation with concentrated fish oil rich in omega-3 polyunsaturated fatty acids in first episode schizophrenia
- (2016) Tomasz Pawełczyk et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Dietary DHA and health: cognitive function ageing
- (2016) Carlos Cardoso et al. NUTRITION RESEARCH REVIEWS
- Association between PLA2G12A Polymorphisms and Schizophrenia in a Han Chinese Population from Northeast China
- (2016) Guang Yang et al. PLoS One
- The association between polyunsaturated fatty acid consumption and the transition to psychosis in ultra-high risk individuals
- (2016) T. Pawełczyk et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- Implications for reactive oxygen species in schizophrenia pathogenesis
- (2016) Minori Koga et al. SCHIZOPHRENIA RESEARCH
- DHA Effects in Brain Development and Function
- (2016) Lotte Lauritzen et al. Nutrients
- Brain development in adolescents at ultra-high risk for psychosis: Longitudinal changes related to resilience
- (2016) Sanne de Wit et al. NeuroImage-Clinical
- Association between serum lipids and membrane fatty acids and clinical characteristics in patients with schizophrenia
- (2015) D. K. Solberg et al. ACTA PSYCHIATRICA SCANDINAVICA
- Omega-3 polyunsaturated fatty acids and brain aging
- (2015) Isabelle Denis et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Vitamin D and the omega-3 fatty acids control serotonin synthesis and action, part 2: relevance for ADHD, bipolar disorder, schizophrenia, and impulsive behavior
- (2015) Rhonda P. Patrick et al. FASEB JOURNAL
- Regulation of neuronal communication by G protein-coupled receptors
- (2015) Yunhong Huang et al. FEBS LETTERS
- Increased levels of IL-6 in the cerebrospinal fluid of patients with chronic schizophrenia — significance for activation of the kynurenine pathway
- (2015) JOURNAL OF PSYCHIATRY & NEUROSCIENCE
- Glutamate and dopamine in schizophrenia: An update for the 21st century
- (2015) Oliver Howes et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium
- (2015) T G M van Erp et al. MOLECULAR PSYCHIATRY
- Human prefrontal cortex phospholipids containing docosahexaenoic acid increase during normal adult aging, whereas those containing arachidonic acid decrease
- (2015) Sarah E. Norris et al. NEUROBIOLOGY OF AGING
- Fatty acid composition of the postmortem prefrontal cortex of patients with schizophrenia, bipolar disorder, and major depressive disorder
- (2015) Kei Hamazaki et al. PSYCHIATRY RESEARCH
- Erythrocyte polyunsaturated fatty acid levels in young people at ultra-high risk for psychotic disorder and healthy adolescent controls
- (2015) Simon M. Rice et al. PSYCHIATRY RESEARCH
- Levels of Red Blood Cell Fatty Acids in Patients With Psychosis, Their Unaffected Siblings, and Healthy Controls
- (2015) Suzanne Medema et al. SCHIZOPHRENIA BULLETIN
- Brain structure in people at ultra-high risk of psychosis, patients with first-episode schizophrenia, and healthy controls: a VBM study
- (2015) Igor Nenadic et al. SCHIZOPHRENIA RESEARCH
- Glutamatergic dysfunction linked to energy and membrane lipid metabolism in frontal and anterior cingulate cortices of never treated first-episode schizophrenia patients
- (2015) Stefan Smesny et al. SCHIZOPHRENIA RESEARCH
- Motivational deficits in early schizophrenia: Prevalent, persistent, and key determinants of functional outcome
- (2015) Gagan Fervaha et al. SCHIZOPHRENIA RESEARCH
- Longer-term outcome in the prevention of psychotic disorders by the Vienna omega-3 study
- (2015) G. Paul Amminger et al. Nature Communications
- Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA
- (2015) Simon C. Dyall Frontiers in Aging Neuroscience
- The role of inflammation in schizophrenia
- (2015) Norbert Müller et al. Frontiers in Neuroscience
- Schizophrenia
- (2015) René S. Kahn et al. Nature Reviews Disease Primers
- Effects of Fish Oil with a High Content of n-3 Polyunsaturated Fatty Acids on Mouse Gut Microbiota
- (2014) Hai-Ning Yu et al. ARCHIVES OF MEDICAL RESEARCH
- Functional characterization of FABP3, 5 and 7 gene variants identified in schizophrenia and autism spectrum disorder and mouse behavioral studies
- (2014) Chie Shimamoto et al. HUMAN MOLECULAR GENETICS
- n-3 Polyunsaturated Fatty Acids Suppress the Localization and Activation of Signaling Proteins at the Immunological Synapse in Murine CD4+ T Cells by Affecting Lipid Raft Formation
- (2014) W. Kim et al. JOURNAL OF IMMUNOLOGY
- Neuroimmune regulation of microglial activity involved in neuroinflammation and neurodegenerative diseases
- (2014) Hugo González et al. JOURNAL OF NEUROIMMUNOLOGY
- Transcriptomic Analysis of the Effects of a Fish Oil Enriched Diet on Murine Brains
- (2014) Rasha Hammamieh et al. PLoS One
- Imaging-Based Neurochemistry in Schizophrenia: A Systematic Review and Implications for Dysfunctional Long-Term Potentiation
- (2014) B. Salavati et al. SCHIZOPHRENIA BULLETIN
- Meta-analysis of cognitive performance in drug-naïve patients with schizophrenia
- (2014) Helena Fatouros-Bergman et al. SCHIZOPHRENIA RESEARCH
- Dopamine dysfunction in schizophrenia
- (2014) Anissa Abi-Dargham SCHIZOPHRENIA RESEARCH
- Relationship between membrane fatty acids and cognitive symptoms and information processing in individuals at ultra-high risk for psychosis
- (2014) Sung-Wan Kim et al. SCHIZOPHRENIA RESEARCH
- Meta-Analysis of Oxidative Stress in Schizophrenia
- (2013) Joshua Flatow et al. BIOLOGICAL PSYCHIATRY
- Long-Chain Omega-3 Fatty Acids Improve Brain Function and Structure in Older Adults
- (2013) A. Veronica Witte et al. CEREBRAL CORTEX
- Altered fatty acid concentrations in prefrontal cortex of schizophrenic patients
- (2013) Ameer Y. Taha et al. JOURNAL OF PSYCHIATRIC RESEARCH
- A serotonin hypothesis of schizophrenia
- (2013) Arnold E. Eggers MEDICAL HYPOTHESES
- Omega-3 fatty acid supplementation changes intracellular phospholipase A2 activity and membrane fatty acid profiles in individuals at ultra-high risk for psychosis
- (2013) S Smesny et al. MOLECULAR PSYCHIATRY
- Lipidomics Reveals Early Metabolic Changes in Subjects with Schizophrenia: Effects of Atypical Antipsychotics
- (2013) Joseph McEvoy et al. PLoS One
- Glutamatergic Dysbalance and Oxidative Stress in In Vivo and In Vitro Models of Psychosis Based on Chronic NMDA Receptor Antagonism
- (2013) Just Genius et al. PLoS One
- n-3 Fatty acids, inflammation and immunity: new mechanisms to explain old actions
- (2013) Philip C. Calder PROCEEDINGS OF THE NUTRITION SOCIETY
- Inflammation and Schizophrenia
- (2013) B. Kirkpatrick et al. SCHIZOPHRENIA BULLETIN
- A randomized placebo-controlled trial of an omega-3 fatty acid and vitamins E+C in schizophrenia
- (2013) H Bentsen et al. Translational Psychiatry
- The Glutamate Hypothesis of Schizophrenia: Neuroimaging and Drug Development
- (2012) Alice Egerton et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Brain Structural Abnormalities at the Onset of Schizophrenia and Bipolar Disorder: A Meta-analysis of Controlled Magnetic Resonance Imaging Studies
- (2012) Luca De Peri et al. CURRENT PHARMACEUTICAL DESIGN
- Evaluation of cognitive learning, memory, psychomotor, immunologic, and retinal functions in healthy puppies fed foods fortified with docosahexaenoic acid–rich fish oil from 8 to 52 weeks of age
- (2012) Steven C. Zicker et al. JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION
- Eicosapentaenoic Acid Interventions in Schizophrenia
- (2012) Paolo Fusar-Poli et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Mechanisms of Action of (n-3) Fatty Acids
- (2012) Philip C. Calder JOURNAL OF NUTRITION
- Fatty acid composition in the postmortem amygdala of patients with schizophrenia, bipolar disorder, and major depressive disorder
- (2012) Kei Hamazaki et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Similarities in serum oxidative stress markers and inflammatory cytokines in patients with overt schizophrenia at early and late stages of chronicity
- (2012) Mariana Pedrini et al. JOURNAL OF PSYCHIATRIC RESEARCH
- The dietary pattern of patients with schizophrenia: A systematic review
- (2012) Salvatore Dipasquale et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Marked reduction of soluble superoxide dismutase-1 (SOD1) in cerebrospinal fluid of patients with recent-onset schizophrenia
- (2012) J M Coughlin et al. MOLECULAR PSYCHIATRY
- Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia
- (2012) S G Fillman et al. MOLECULAR PSYCHIATRY
- Cognitive enhancement by omega-3 fatty acids from child-hood to old age: Findings from animal and clinical studies
- (2012) Dirk W. Luchtman et al. NEUROPHARMACOLOGY
- NMDA receptors and metaplasticity: Mechanisms and possible roles in neuropsychiatric disorders
- (2012) Charles F. Zorumski et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Dopaminergic Neurotransmission in Patients with Schizophrenia in Relation to Positive and Negative Symptoms
- (2012) O. Pogarell et al. PHARMACOPSYCHIATRY
- Reduced antioxidant defense systems in schizophrenia and bipolar I disorder
- (2012) Monia Raffa et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Immuno-inflammatory, oxidative and nitrosative stress, and neuroprogressive pathways in the etiology, course and treatment of schizophrenia
- (2012) George Anderson et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia
- (2012) Kyoung-Sae Na et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Clinical and biochemical validation of two endophenotypes of schizophrenia defined by levels of polyunsaturated fatty acids in red blood cells
- (2012) H. Bentsen et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- Deciphering the role of docosahexaenoic acid in brain maturation and pathology with magnetic resonance imaging
- (2012) Robert K. McNamara PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- Translational studies on regulation of brain docosahexaenoic acid (DHA) metabolism in vivo
- (2012) Stanley I. Rapoport PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- Membrane lipid raft organization is uniquely modified by n-3 polyunsaturated fatty acids
- (2012) Harmony F. Turk et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- Red blood cell polyunsaturated fatty acids measured in red blood cells and schizophrenia: A meta-analysis
- (2012) Wendela P. Hoen et al. PSYCHIATRY RESEARCH
- Progressive membrane phospholipid changes in first episode schizophrenia with high field magnetic resonance spectroscopy
- (2012) Jodi Miller et al. PSYCHIATRY RESEARCH-NEUROIMAGING
- Plasma total antioxidant status and cognitive impairments in schizophrenia
- (2012) Xiang Yang Zhang et al. SCHIZOPHRENIA RESEARCH
- A meta-analysis of the polyunsaturated fatty acid composition of erythrocyte membranes in schizophrenia
- (2012) W.J.M. van der Kemp et al. SCHIZOPHRENIA RESEARCH
- Neuroanatomical Abnormalities That Predate the Onset of Psychosis
- (2011) Andrea Mechelli et al. ARCHIVES OF GENERAL PSYCHIATRY
- Bimodal Distribution of Polyunsaturated Fatty Acids in Schizophrenia Suggests Two Endophenotypes of the Disorder
- (2011) Håvard Bentsen et al. BIOLOGICAL PSYCHIATRY
- Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects
- (2011) Brian J. Miller et al. BIOLOGICAL PSYCHIATRY
- Decreased glutathione levels and impaired antioxidant enzyme activities in drug-naive first-episode schizophrenic patients
- (2011) Monia Raffa et al. BMC Psychiatry
- Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
- (2011) Edward A. Dennis et al. CHEMICAL REVIEWS
- Therapeutic use of omega-3 fatty acids in bipolar disorder
- (2011) Vicent Balanzá-Martínez et al. Expert Review of Neurotherapeutics
- Evolutionary Aspects of Diet: The Omega-6/Omega-3 Ratio and the Brain
- (2011) Artemis P. Simopoulos MOLECULAR NEUROBIOLOGY
- Neuroinflammation in schizophrenia especially focused on the role of microglia
- (2011) Akira Monji et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Age of Onset of Schizophrenia: Perspectives From Structural Neuroimaging Studies
- (2011) N. Gogtay et al. SCHIZOPHRENIA BULLETIN
- Differential effects of antipsychotic medications on polyunsaturated fatty acid biosynthesis in rats: Relationship with liver delta6-desaturase expression
- (2011) Robert K. McNamara et al. SCHIZOPHRENIA RESEARCH
- Docosahexaenoic Acid (DHA): An Ancient Nutrient for the Modern Human Brain
- (2011) Joanne Bradbury Nutrients
- Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline
- (2010) Karin Yurko-Mauro et al. Alzheimers & Dementia
- Long-Chain ω-3 Fatty Acids for Indicated Prevention of Psychotic Disorders
- (2010) G. Paul Amminger et al. ARCHIVES OF GENERAL PSYCHIATRY
- Docosahexaenoic acid (DHA) and the developing central nervous system (CNS) – Implications for dietary recommendations
- (2010) Philippe Guesnet et al. BIOCHIMIE
- Fatty acid binding proteins in brain development and disease
- (2010) Rong-Zong Liu et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY
- Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders
- (2010) Jeremy W. Gawryluk et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Mechanisms of n-3 fatty acid-mediated development and maintenance of learning memory performance
- (2010) Hui-Min Su JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Phospholipase A2 activity is associated with structural brain changes in schizophrenia
- (2010) Stefan Smesny et al. NEUROIMAGE
- Oxidative stress in schizophrenia: An integrated approach
- (2010) Byron K.Y. Bitanihirwe et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Developmental effects of dietary n−3 fatty acids on activity and response to novelty
- (2010) Beth Levant et al. PHYSIOLOGY & BEHAVIOR
- Polyunsaturated fatty acids deficits are associated with psychotic state and negative symptoms in patients with schizophrenia
- (2010) M.M. Sethom et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- Neuroprotective effects of ethyl-eicosapentaenoic acid in first episode psychosis: A longitudinal T2 relaxometry pilot study
- (2010) Stephen J. Wood et al. PSYCHIATRY RESEARCH-NEUROIMAGING
- Progressive Structural Brain Changes During Development of Psychosis
- (2010) Tim B. Ziermans et al. SCHIZOPHRENIA BULLETIN
- Phospholipase A2activity in first episode schizophrenia: Associations with symptom severity and outcome at week 12
- (2010) Stefan Smesny et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Intracellular- and extracellular-derived Ca2+ influence phospholipase A2-mediated fatty acid release from brain phospholipids
- (2009) Angelo O. Rosa et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Docosahexaenoic Acid Modifies the Clustering and Size of Lipid Rafts and the Lateral Organization and Surface Expression of MHC Class I of EL4 Cells
- (2009) Saame Raza Shaikh et al. JOURNAL OF NUTRITION
- Cognitive deficits in recent-onset and chronic schizophrenia
- (2009) S.R. Sponheim et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Activation of brain interleukin-1β in schizophrenia
- (2009) J Söderlund et al. MOLECULAR PSYCHIATRY
- Prostaglandins of the E series inhibit monoamine release via EP3 receptors: proof with the competitive EP3 receptor antagonist L-826,266
- (2009) J. Günther et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Diffusion of docosahexaenoic and eicosapentaenoic acids through the blood–brain barrier: An in situ cerebral perfusion study
- (2009) Melissa Ouellet et al. NEUROCHEMISTRY INTERNATIONAL
- Phospholipases A2 and Inflammatory Responses in the Central Nervous System
- (2009) Grace Y. Sun et al. NEUROMOLECULAR MEDICINE
- Oxidative/Nitrative Modifications of Plasma Proteins and Thiols from Patients with Schizophrenia
- (2009) Anna Dietrich-Muszalska et al. NEUROPSYCHOBIOLOGY
- Delayed cell migration in the developing rat brain following maternal omega 3 alpha linolenic acid dietary deficiency
- (2009) E. Yavin et al. NEUROSCIENCE
- Brain Anatomical Abnormalities in High-Risk Individuals, First-Episode, and Chronic Schizophrenia: An Activation Likelihood Estimation Meta-analysis of Illness Progression
- (2009) R. C. K. Chan et al. SCHIZOPHRENIA BULLETIN
- Cognitive Impairment in Schizophrenia and Affective Psychoses: Implications for DSM-V Criteria and Beyond
- (2009) E. Bora et al. SCHIZOPHRENIA BULLETIN
- Schizophrenia: From the brain to peripheral markers. A consensus paper of the WFSBP task force on biological markers
- (2009) Gerald Stöber et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- The emerging role of group VI calcium-independent phospholipase A2in releasing docosahexaenoic acid from brain phospholipids: Fig. 1.
- (2008) Joshua T. Green et al. JOURNAL OF LIPID RESEARCH
- Expression of E-FABP in PC12 cells increases neurite extension during differentiation: involvement of n-3 and n-6 fatty acids
- (2008) Jo-Wen Liu et al. JOURNAL OF NEUROCHEMISTRY
- Prenatal long-chain polyunsaturated fatty acid status: the importance of a balanced intake of docosahexaenoic acid and arachidonic acid
- (2008) Mijna Hadders-Algra JOURNAL OF PERINATAL MEDICINE
- The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: A preliminary randomized double-blind placebo-controlled study
- (2008) Chih-Chiang Chiu et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- BanI polymorphism of cytosolic phospholipase A2 gene is associated with age at onset in male patients with schizophrenia and schizoaffective disorder
- (2008) S. Nadalin et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- The aging human orbitofrontal cortex: Decreasing polyunsaturated fatty acid composition and associated increases in lipogenic gene expression and stearoyl-CoA desaturase activity
- (2008) Robert K. McNamara et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- Semantic memory in schizophrenia: Association with cell membrane essential fatty acids
- (2008) Ruth Condray et al. SCHIZOPHRENIA RESEARCH
- Altered antioxidant defense system in clinically stable patients with schizophrenia and their unaffected siblings
- (2007) Leila Ben Othmen et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Essential polyunsaturated fatty acids and social cognition in schizophrenia
- (2007) Tomiki Sumiyoshi et al. PSYCHIATRY RESEARCH
- Opposite changes in predominantly docosahexaenoic acid (DHA) in cerebrospinal fluid and red blood cells from never-medicated first-episode psychotic patients
- (2007) Anvita Kale et al. SCHIZOPHRENIA RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started